These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21649845)

  • 41. Sleep quality in patients with hypertension: additional negative effect of drug therapy.
    Yontar OC; Erdem A; Yilmaz MB
    Sleep Med; 2009 Dec; 10(10):1168; author reply 1168-9. PubMed ID: 19467925
    [No Abstract]   [Full Text] [Related]  

  • 42. Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).
    Black HR; Aguirre P F; Wright M; Alessi T; Baschiera F
    J Clin Hypertens (Greenwich); 2012 Aug; 14(8):514-21. PubMed ID: 22863159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antihypertensive efficacy and tolerability of nebivolol].
    Kirichenko AA; Mironova EV
    Kardiologiia; 2002; 42(12):35-7. PubMed ID: 12494015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW; Lin Y; Pejović V; Bowen L
    Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
    Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of aliskiren in Latin America in a real-world setting: aliskiren in Latin America Study (ALAS).
    Volman S; Benitez FN; Cedenio H; Giorgi M; Jaramillo N; Molina N; Zilberman J
    Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):189-96. PubMed ID: 23723254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J; Faulhaber HD
    Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark?
    Messerli FH; Bangalore S
    Circulation; 2009 Jan; 119(3):371-3. PubMed ID: 19171867
    [No Abstract]   [Full Text] [Related]  

  • 52. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y; Arnott W
    J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study.
    Chan TY; Woo KS; Nicholls MG
    Int J Cardiol; 1992 Jun; 35(3):387-95. PubMed ID: 1351888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract]   [Full Text] [Related]  

  • 56. Antihypertensive treatment and sexual dysfunction.
    Manolis A; Doumas M
    Curr Hypertens Rep; 2012 Aug; 14(4):285-92. PubMed ID: 22581395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of nebivolol on left ventricular hypertrophy in hypertension.
    Liu GS; Wang LY; Nueten LV; Ooms LA; Borgers M; Janssen PA
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):549-51. PubMed ID: 10686666
    [No Abstract]   [Full Text] [Related]  

  • 58. A new weapon against hypertension. Recently approved medication lowers blood pressure, reducing risks of heart failure, stroke, heart attack, aneurysm, and kidney failure.
    Heart Advis; 2007 Jun; 10(6):3. PubMed ID: 17654793
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
    Sica D; Gradman AH; Lederballe O; Kolloch RE; Zhang J; Keefe DL
    Clin Drug Investig; 2011 Dec; 31(12):825-37. PubMed ID: 22035463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension.
    Hripcsak G; Suchard MA; Shea S; Chen R; You SC; Pratt N; Madigan D; Krumholz HM; Ryan PB; Schuemie MJ
    JAMA Intern Med; 2020 Apr; 180(4):542-551. PubMed ID: 32065600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.